lilly trials retatrutide Today, we shared new data from two Phase 3 of retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v Retatrutide Exhibits Meaningful Weight Loss

The Melanoma Study That Changes the Conversation One study deserves special attention in any discussion of BPC-157 and cancer

The authors suggest that inhibition of FAO may lead to an overall decrease in cancer cell survival, while an increase in CPT1 activity, such as the PRL-mediated response, may provide a supportive environment for malignant cells 36

The Impact of Exercise Moving your body intentionally is a powerful way to optimize your metabolism

Your Questions Answered Led by trained medical professionals delivering safe, effective, and scientifically backed aesthetic and wellness treatments

DSIP exhibits an amphiphilic structure, allowing interaction with both aqueous and lipid environments, which may influence receptor binding and cellular distribution